Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Adicionar filtros








Intervalo de ano
1.
Biomolecules & Therapeutics ; : 519-527, 2017.
Artigo em Inglês | WPRIM | ID: wpr-38705

RESUMO

Excessive activation of microglia causes the continuous production of neurotoxic mediators, which further causes neuron degeneration. Therefore, inhibition of microglial activation is a possible target for the treatment of neurodegenerative disorders. Balanophonin, a natural neolignoid from Firmiana simplex, has been reported to have anti-inflammatory and anti-cancer effects. In this study, we aimed to evaluate the anti-neuroinflammatory effects and mechanism of balanophonin in lipopolysaccharide (LPS)-stimulated BV2 microglia cells. BV2 microglia cells were stimulated with LPS in the presence or absence of balanophonin. The results indicated that balanophonin reduced not only the LPS-mediated TLR4 activation but also the production of inflammatory mediators, such as nitric oxide (NO), prostaglandin E2 (PGE2), Interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), in BV2 cells. Balanophonin also inhibited LPS-induced inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX2) protein expression and mitogen activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 MAPK. Interestingly, it also inhibited neuronal cell death resulting from LPS-activated microglia by regulating cleaved caspase-3 and poly ADP ribose polymerase (PARP) cleavage in N2a cells. In conclusion, our data indicated that balanophonin may delay the progression of neuronal cell death by inhibiting microglial activation.


Assuntos
Apoptose , Caspase 3 , Morte Celular , Ciclo-Oxigenase 2 , Dinoprostona , Proteínas Quinases JNK Ativadas por Mitógeno , Microglia , Proteínas Quinases Ativadas por Mitógeno , Necrose , Degeneração Neural , Doenças Neurodegenerativas , Neurônios , Neuroproteção , Óxido Nítrico , Óxido Nítrico Sintase Tipo II , Proteínas Quinases p38 Ativadas por Mitógeno , Fosfotransferases , Poli(ADP-Ribose) Polimerases
2.
Korean Journal of Dermatology ; : 404-406, 2016.
Artigo em Inglês | WPRIM | ID: wpr-121745

RESUMO

No abstract available.


Assuntos
Feminino , Humanos , Adulto Jovem , Piercing Corporal , Orelha
3.
Annals of Dermatology ; : 249-250, 2016.
Artigo em Inglês | WPRIM | ID: wpr-136921

RESUMO

No abstract available.


Assuntos
Esclerodermia Localizada , Vitiligo
4.
Annals of Dermatology ; : 249-250, 2016.
Artigo em Inglês | WPRIM | ID: wpr-136916

RESUMO

No abstract available.


Assuntos
Esclerodermia Localizada , Vitiligo
6.
Korean Journal of Dermatology ; : 519-521, 2014.
Artigo em Coreano | WPRIM | ID: wpr-173278

RESUMO

No abstract available.


Assuntos
Feminino , Humanos , Herpes Simples , Mastite
7.
Yonsei Medical Journal ; : 1648-1655, 2014.
Artigo em Inglês | WPRIM | ID: wpr-180230

RESUMO

PURPOSE: Recent findings of increased cathelicidin protein and its proteolytic fragments in rosacea suggest a pathogenic role for cathelicidin in this disease. The relationship between cathelicidin and protease-activated receptor 2 (PAR-2) is therefore of interest, as PAR-2, expressed principally in keratinocytes, regulates pro-inflammatory cytokine expression in the skin. The purpose of this study was to determine the relationship between expression of PAR-2 and cathelicidin in rosacea and to test the effect of direct PAR-2 activation on cathelicidin expression in keratinocytes. MATERIALS AND METHODS: Samples from 40 patients with clinicopathologic diagnosis of rosacea and facial skin tissue samples from 20 patients with no specific findings or milium without inflammation were retrieved. Intensities of immunohistochemical staining for PAR-2 and cathelicidin were compared between normal and rosacea-affected skin tissues. Additionally, correlations between PAR-2 and cathelicidin staining intensities within rosacea patients were analyzed. In cultured keratinocytes, changes in PAR-2, cathelicidin, and vascular endothelial growth factor (VEGF) mRNA and protein were analyzed after treatment with PAR-2 activating peptide (AP). RESULTS: Cathelicidin expression was significantly higher in rosacea skin tissues than in normal tissues (p<0.001), while PAR-2 expression was not significantly higher in rosacea tissues than in normal skin tissues. A positive correlation between PAR-2 and cathelicidin within rosacea samples was observed (R=0.330, p=0.037). After treatment of PAR-2 AP, both mRNA and protein levels for PAR-2, cathelicidin, and VEGF significantly increased in cultured keratinocytes, compared with PAR-2 control peptide treatment. CONCLUSION: PAR-2 may participate in the pathogenesis of rosacea through activation of cathelicidin LL-37, a mediator of innate immune responses in the skin.


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Peptídeos Catiônicos Antimicrobianos/metabolismo , Citocinas/metabolismo , Imunidade Inata , Inflamação/metabolismo , Queratinócitos/metabolismo , Receptor PAR-2/metabolismo , Rosácea/patologia , Pele/patologia , Fator A de Crescimento do Endotélio Vascular/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA